WTAP介导的RNA m6A修饰促进特应性皮炎病理生理
该研究利用m6A-mRNA表观转录组芯片筛查特应性皮炎(AD)患者差异表达基因及其m6A水平与相关酶,发现WTAP及S100A9、SERPINB3在AD角质形成细胞中显著上调,WTAP通过m6A修饰促进这两个基因表达,加剧角质形成细胞增殖与分化异常,且与AD严重程度相关。
要点
- WTAP在AD患者表皮病变角质形成细胞中显著上调。
- WTAP介导m6A修饰上调S100A9和SERPINB3表达。
- WTAP、S100A9、SERPINB3表达与AD严重程度相关。
核心结论
- WTAP介导的m6A修饰通过促进S100A9和SERPINB3表达,加剧人表皮角质形成细胞增殖和分化异常,参与AD病理生理发展。
研究设计与样本
- 使用Arraystar m6A-mRNA表观转录组芯片筛查AD患者差异表达基因及其m6A水平与m6A相关酶。
- 在公共数据和AD患者表皮病变中验证候选基因,并进行体外细胞实验。
主要发现
- WTAP和候选差异基因S100A9、SERPINB3在AD患者角质形成细胞中显著上调。
- 体外实验证实WTAP影响S100A9和SERPINB3表达,促进原代人表皮角质形成细胞增殖并抑制其分化。
- WTAP、S100A9和SERPINB3表达与AD严重程度相关。
临床怎么用
- WTAP及其介导的m6A修饰可能作为AD病理机制的潜在干预靶点。
- S100A9和SERPINB3或可作为反映AD严重程度的候选生物标志物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
N6-methyladenosine (m6A) is the most abundant dynamic and reversible internal chemical modification of RNA in eukaryotic cells and is essential in multiple pathophysiological processes. However, it has not been reported in atopic dermatitis (AD). We used Arraystar m6A-mRNA epitranscriptomic microarray to screen for differentially expressed genes and their m6A levels and m6A-related enzymes in patients with AD. We confirmed that the m6A RNA methyltransferase WTAP and 2 candidate differentially expressed genes (S100A9 and SERPINB3) were significantly upregulated in keratinocytes in public data and epidermal lesions of patients with AD. In vitro cell experiments confirmed that WTAP influenced the expression of the 2 candidate differentially expressed genes and promoted primary human epidermal keratinocyte proliferation while inhibiting human epidermal keratinocyte differentiation. Furthermore, we showed that WTAP, S100A9, and SERPINB3 expression correlated with AD severity. Our findings revealed that WTAP-mediated m6A modification promoted the expression of S100A9 and SERPINB3 to aggravate human epidermal keratinocyte proliferation and dysdifferentiation contributing to the pathophysiological development of AD.
引用
- Tan L, Chen X, Yan S, et al. WTAP-Mediated N6-Methyladenosine of RNAs Facilitate the Pathophysiology of Atopic Dermatitis. J Invest Dermatol. 2023. PMID: 38029838. doi:10.1016/j.jid.2023.10.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。